Publications Office of the EU
Belgium-Brussels: Development, Production, Priority-purchasing Options and Supply of COVID-19 Vaccines for EU Member States - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Belgium-Brussels: Development, Production, Priority-purchasing Options and Supply of COVID-19 Vaccines for EU Member States

  • Awarded
    04/08/2021
  • Today
    22/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
European Commission
Place of performance
NUTS code: BE10 Région de Bruxelles-Capitale / Brussels Hoofdstedelijk Gewest
Location of buyer
NUTS code: BE100 Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad
Business sector (Main CPV)
33651600 Vaccines
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
1.00 EUR
Tender reference number
Not available
Description

The subject of this tender is financing the research, development and manufacturing of a COVID-19 vaccine in accordance with the applicable legislation, and securing the purchase of certain vaccine doses for the participating Member States.

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Award method
The most economic tender
Estimated value
Not available
Final contracted value
1.00 EUR
Award of contract
Official name: Novavax Inc
Postal address: 21 Firstfield Road
Town: Gaithersburg, MD
Postal code: 20878
Country: USA
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.